Actinium Pharmaceuticals
ATNM
$9.69
Share price
-1.12%
Change (1 day)
8.27%
Change (1 year)
Categories
Operating Margin for Actinium Pharmaceuticals (ATNM)
Operating Margin as of May 2024 (TTM): -2,930.76%
According to Actinium Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -2,930.76%. At the end of 2021 the company had an Operating Margin of -2,165.56%.
Operating Margin history for Actinium Pharmaceuticals from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,165.56% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | -1,084.89% | -62.98% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -55.07% | -98.12% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 4.83% | -100.16% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.